This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $715,275
Effectiveness and Safety of Long-term Antiresorptive Treatment for Osteoporosis in Canada: Improving Shared Decision Making
CIHR · 2023 · Co-investigator
- $250,000
Development of a Common Data Model across selected CNODES sites
CIHR · 2017 · Principal investigator
- $17,500,000
Canadian Network for Observational Drug Effect Studies (CNODES)
CIHR · 2016 · Co-investigator
Effectiveness and Safety of Long-term Antiresorptive Treatment for Osteoporosis in Canada: Improving Shared Decision Making
Principal investigators: Morin, Suzanne N; Leslie, William D; Lix, Lisa M
Keywords: Administrative Data Analysis; Antiresorptive Drug Therapy; Bone Mineral Density; Cohort Study; Fractures; Osteoporosis; Safety; Shared Decision Making
Development of a Common Data Model across selected CNODES sites
Principal investigators: Platt, Robert W; Henry, David A; Paterson, Michael; Suissa, Samy
Keywords: Dsen
Canadian Network for Observational Drug Effect Studies (CNODES)
Principal investigators: Suissa, Samy; Dormuth, Colin R; Henry, David A; Platt, Robert W; Sketris, Ingrid S
Keywords: Databases; Drug Effectiveness; Drug Safety; Observational Studies; Pharmacoepidemiology
Canadian Network for Observational Drug Effect Studies (CNODES)
Principal investigators: Suissa, Samy; Dormuth, Colin R; Henry, David A; Levy, Adrian R; Martens, Patricia J; Platt, Robert W
Keywords: Databases; Drug Effectiveness; Drug Safety; Observational Studies; Pharmacoepidemiology
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.